Insider transactions

Thomas F Ackerman

CIK 1141720 · Corporate Executive VP & CFO · last filed 2026-05-20

Thomas F Ackerman is a Corporate Executive VP & CFO who has filed 101 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for AORT, was dated May 20, 2026. Across all open-market trades the lifetime net is −$24.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $37.4M across reported positions. 28 SEC filings were submitted jointly with CRYOLIFE INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$37.41M
Companies
3
Total Filings
101
Lifetime Open-Market Net
-$24.42M

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

Filer Profile

Reported Address
251 BALLARDVALE ST
WILMINGTON, MA 01887
Related Filers
CRYOLIFE INC — 28 joint filings, latest 2026-05-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AORT Director 157,472 $22.34 $3.52M $0 6 2026-05-20
CRY Director 119,695 $15.60 $1.87M -$112.9K 17 2021-06-02
CRL 107,432 $298.10 $32.03M -$24.31M 78 2016-03-01

Recent Filings

101 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-20 AORT Grant (A) +7,576 $0 EDGAR
2025-05-27 AORT Grant (A) +6,325 $0 EDGAR
2024-06-03 AORT Grant (A) +6,289 $0 EDGAR
2023-06-08 AORT Grant (A) +9,709 $0 EDGAR
2022-06-03 AORT Grant (A) +7,878 $150.0K EDGAR
2021-06-02 CRY Grant (A) +4,423 $130.0K EDGAR
2020-06-02 CRY Grant (A) +5,667 $130.0K EDGAR
2020-05-06 CRY Grant (A) +1,455 $0 EDGAR
2019-05-17 CRY Grant (A) +4,163 $0 EDGAR
2018-05-25 CRY Grant (A) +4,638 $0 EDGAR
Showing 1–10 of 101
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.